Valuation Dr. Reddy's Laboratories Limited

Stocks

Market Closed - Bombay S.E. 06:29:49 2026-10-16 EDT			5-day change	1st Jan Change
1,231.85 ^INR	+0.91%		+3.08%	-3.08%

10-16	Asian Equities Traded in the US as American Depositary Receipts Edge Higher in Friday Trading	MT
10-14	Dr. Reddy's Laboratories Limited Receives Form 483 with Three Observations from United States Food and Drug Administration	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	714,500	767,655	1,024,969	953,168	1,044,616	1,026,112	-	-
Change	-	7.44%	33.52%	-7.01%	9.59%	-1.77%	-	-
Enterprise Value (EV) ¹	703,980	719,330	960,383	928,633	1,011,902	994,154	974,746	945,503
Change	-	2.18%	33.51%	-3.31%	8.97%	-1.75%	-1.95%	-3%
P/E	30.4x	17.1x	18.4x	16.9x	24.4x	27.8x	21.4x	17.9x
PBR	3.76x	3.33x	3.63x	2.86x	2.78x	2.52x	2.29x	2.07x
PEG	-	0.2x	0.8x	13.12x	-1x	-2x	0.7x	0.9x
Capitalization / Revenue	3.33x	3.11x	3.67x	2.93x	3.11x	2.92x	2.61x	2.38x
EV / Revenue	3.28x	2.92x	3.44x	2.85x	3.01x	2.82x	2.48x	2.19x
EV / EBITDA	13.7x	11.1x	12.1x	10.8x	15.1x	16.1x	12.3x	10.4x
EV / EBIT	20.5x	13.8x	14.8x	13.4x	21.8x	24.4x	17.5x	13.9x
EV / FCF	52.3x	15.1x	33.1x	49.1x	30.3x	25.4x	27x	19.6x
FCF Yield	1.91%	6.61%	3.02%	2.04%	3.3%	3.94%	3.7%	5.09%
Dividend per Share ²	6	8	8	8	8	7.576	8.403	9.088
Rate of return	0.7%	0.87%	0.65%	0.7%	0.64%	0.61%	0.68%	0.74%
EPS ²	28.34	54.18	66.92	67.78	51.42	44.27	57.69	68.84
Distribution rate	21.2%	14.8%	12%	11.8%	15.6%	17.1%	14.6%	13.2%
Net sales ¹	214,391	246,697	279,164	325,535	335,933	351,921	393,108	431,961
EBITDA ¹	51,400	64,559	79,481	86,236	67,048	61,844	79,414	91,051
EBIT ¹	34,277	52,057	64,781	69,178	46,443	40,764	55,774	67,869
Net income ¹	23,568	45,073	55,779	56,544	42,850	36,531	48,570	57,436
Net Debt ¹	-10,520	-48,325	-64,586	-24,535	-32,714	-31,957	-51,365	-80,608
Reference price ²	861.08	924.30	1,231.03	1,144.05	1,254.65	1,231.85	1,231.85	1,231.85
Nbr of stocks (in thousands)	829,771	830,526	832,611	833,152	832,596	832,984	-	-
Announcement Date	5/19/22	5/10/23	5/7/24	5/9/25	5/12/26	-	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
DR. REDDY'S LABORATORIES LIMITED	27.83x	2.82x	16.08x	0.62%	10.81B
ELI LILLY AND COMPANY	35.96x	12.96x	27.14x	0.55%	1,120B
JOHNSON & JOHNSON	37.4x	6.3x	17.74x	2.09%	616B
ABBVIE INC.	36.43x	8.36x	17.24x	2.43%	504B
ROCHE HOLDING AG	20.46x	4.99x	12.38x	2.64%	367B
MERCK & CO., INC.	106.52x	5.95x	25.12x	2.33%	360B
NOVARTIS AG	21.18x	5.54x	13.63x	2.88%	288B
ASTRAZENECA PLC	21.7x	4.38x	12.55x	2.01%	258B
AMGEN INC.	27.46x	7.06x	12.64x	2.33%	234B
GILEAD SCIENCES, INC.	-45.63x	6.99x	27.07x	2.11%	194B
Average	28.93x	6.54x	18.16x	2%	395.17B
Weighted average by Cap.	34.70x	8.19x	20.03x	1.83%